Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Abstract Background Magnetic resonance-guided radiotherapy (MRgRT) utilization is rapidly expanding, driven by advanced capabilities including better soft tissue imaging, continuous intrafraction target visualization, automatic triggered beam delivery, and the availability of on-table adaptive repla...

Full description

Bibliographic Details
Main Authors: Berend J. Slotman, Mary Ann Clark, Enis Özyar, Myungsoo Kim, Jun Itami, Agnès Tallet, Jürgen Debus, Raphael Pfeffer, PierCarlo Gentile, Yukihiro Hama, Nicolaus Andratschke, Olivier Riou, Philip Camilleri, Claus Belka, Magali Quivrin, BoKyong Kim, Anders Pedersen, Mette van Overeem Felter, Young Il Kim, Jin Ho Kim, Martin Fuss, Vincenzo Valentini
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Radiation Oncology
Subjects:
MRI-guided radiotherapy
MR-IGRT
Stereotactic body radiotherapy
SBRT
Stereotactic ablative radiation therapy
SABR
Online Access:https://doi.org/10.1186/s13014-022-02114-2

Internet

https://doi.org/10.1186/s13014-022-02114-2

Similar Items